77 related articles for article (PubMed ID: 13977)
1. Metabolic fate of phenobarbital. A quantitative study of p-hydroxyphenobarbital elimination in man.
Whyte MP; Dekaban AS
Drug Metab Dispos; 1977; 5(1):63-70. PubMed ID: 13977
[TBL] [Abstract][Full Text] [Related]
2. Sample stacking microemulsion electrokinetic capillary chromatography induced by reverse migrating pseudostationary phase for the quantification of phenobarbital and its p-hydroxyphenobarbital metabolite in rat urine.
Kadi A; Hefnawy M; Julkhuf S; Abounassif M; Mostafa G; Kassem MG; Attia S; Al-Ghamdi A
Analyst; 2011 Jul; 136(13):2858-65. PubMed ID: 21607283
[TBL] [Abstract][Full Text] [Related]
3. The effect of liver disease in man on the disposition of phenobarbital.
Alvin J; McHorse T; Hoyumpa A; Bush MT; Schenker S
J Pharmacol Exp Ther; 1975 Jan; 192(1):224-35. PubMed ID: 235636
[TBL] [Abstract][Full Text] [Related]
4. Metabolic fate of phenobarbital in man. N-Glucoside formation.
Tang BK; Kalow W; Grey AA
Drug Metab Dispos; 1979; 7(5):315-8. PubMed ID: 40773
[TBL] [Abstract][Full Text] [Related]
5. Development of phenobarbital glucosidation in the human neonate.
Bhargava VO; Garrettson LK
Dev Pharmacol Ther; 1988; 11(1):8-13. PubMed ID: 3383723
[TBL] [Abstract][Full Text] [Related]
6. Qualitative and quantitative studies of methylphenobarbital metabolism in man.
Hooper WD; Kunze HE; Eadie MJ
Drug Metab Dispos; 1981; 9(4):381-5. PubMed ID: 6114839
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of dimethoxymethyl phenobarbital (eterobarb) in patients with epilepsy.
Goldberg MA; Gal J; Cho AK; Jenden DJ
Ann Neurol; 1979 Feb; 5(2):121-6. PubMed ID: 426475
[TBL] [Abstract][Full Text] [Related]
8. Impaired biliary excretion of acetaminophen glucuronide in the isolated perfused rat liver after acute phenobarbital treatment and in vivo phenobarbital pretreatment.
Studenberg SD; Brouwer KL
J Pharmacol Exp Ther; 1992 Jun; 261(3):1022-7. PubMed ID: 1602370
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of phenobarbital and its metabolite p-hydroxyphenobarbital in convulsing and non-convulsing patients.
Brzakovic B; Pokrajac M; Dzoljic E; Levic Z; Varagic VM
Eur J Drug Metab Pharmacokinet; 1999; 24(3):233-6. PubMed ID: 10716061
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and disposition of naltrexone in man after oral and intravenous administration.
Wall ME; Brine DR; Perez-Reyes M
Drug Metab Dispos; 1981; 9(4):369-75. PubMed ID: 6114837
[TBL] [Abstract][Full Text] [Related]
11. Quantitative determination of the urinary excretion of ketobemidone and four of its metabolites after intravenous and oral administration in man.
Bondesson U; Hartvig P; Danielsson B
Drug Metab Dispos; 1981; 9(4):376-80. PubMed ID: 6114838
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of drug action in disease states. II. Effect of experimental renal dysfunction on phenobarbital concentrations in rats at onset of loss of righting reflect.
Danhof M; Hisaoka M; Levy G
J Pharmacol Exp Ther; 1984 Sep; 230(3):627-31. PubMed ID: 6332189
[TBL] [Abstract][Full Text] [Related]
13. The metabolic fate of stiripentol in man.
Moreland TA; Astoin J; Lepage F; Tombret F; Levy RH; Baillie TA
Drug Metab Dispos; 1986; 14(6):654-62. PubMed ID: 2877822
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of phenobarbital and p-hydroxyphenobarbital and their stable isotope labeled analogs by gas chromatography mass spectrometry.
Van Langenhove A; Biller JE; Biemann K; Browne TR
Biomed Mass Spectrom; 1982 May; 9(5):201-7. PubMed ID: 7093441
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of phenobarbitone and its metabolites in chronically treated patients.
Bernus I; Dickinson RG; Hooper WD; Eadie MJ
Eur J Clin Pharmacol; 1994; 46(5):473-5. PubMed ID: 7957546
[TBL] [Abstract][Full Text] [Related]
16. Modulation of trans-4-acetylaminostilbene metabolism in the rat by methylcholanthrene and phenobarbital and its relevance for acute toxicity.
Pfeifer A; Neumann HG
Drug Metab Dispos; 1988; 16(2):276-84. PubMed ID: 2898347
[TBL] [Abstract][Full Text] [Related]
17. [Concentration of phenobarbital in biological fluids during the treatment of epilepsy patients].
Okudzhava VM; Antadze ZI; Vetrogon FG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(6):879-82. PubMed ID: 6464609
[TBL] [Abstract][Full Text] [Related]
18. Determination of phenobarbital, p-hydroxyphenobarbital and phenobarbital-N-glucoside in urine by gas chromatography chemical ionization mass spectrometry.
Tang BK; Yilmaz B; Kalow W
Biomed Mass Spectrom; 1984 Sep; 11(9):462-5. PubMed ID: 6509155
[TBL] [Abstract][Full Text] [Related]
19. The metabolism and excretion of enzyme-inducing doses of phenobarbital by rats with bile fistulas.
Levin SS; Vars HM; Schleyer H; Cooper DY
Xenobiotica; 1986 Mar; 16(3):213-24. PubMed ID: 3705618
[TBL] [Abstract][Full Text] [Related]
20. Effect of diphenylhydantoin and its main hydroxylated metabolite on the pharmacokinetics and the urinary and biliary excretion of phenobarbital and its p-hydroxy metabolite.
Sarhan F; Engasser JM; Batt AM; Magdalou J; Siest G
Eur J Drug Metab Pharmacokinet; 1981; 6(2):99-108. PubMed ID: 7306277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
